Summary by Futu AI
Wawang Pharmaceutical (China) Co., Ltd has announced the list of its Board members and their respective roles and functions. The Board has a total of 10 members, including Executive Director Mr. Tu Chi Keung (Chairman), Dr. Su Lui Kwok (Chief Executive Officer and Chief Scientific Officer) and Mr. Zheng Ze Fung (Chief Financial Officer). Non-executive directors include Dr Dan Eldar and Ms Shi Tak, while independent non-executive directors include Mr Paul Rutherford CARTER (Senior Independent Director). The Company also lists in detail the roles of Board members on various committees, including Audit Committee, Nomination Committee, Remuneration Committee, Sustainability Committee, and Technical Committee. The announcement was made on 13 May 2024.